Shree Ganesh Remedies Ltd

Company Profile

Shree Ganesh Remedies Ltd had its IPO on under the ticker symbol SGRL.

The company operates in the sector and industry. Shree Ganesh Remedies Ltd has a staff strength of 0 employees.

Stock update

Shares of Shree Ganesh Remedies Ltd opened at ₹485 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹476.15 - ₹498.75, and closed at ₹489.65.

This is a +2.39% increase from the previous day's closing price.

A total volume of 147,764 shares were traded at the close of the day’s session.

In the last one week, shares of Shree Ganesh Remedies Ltd have increased by +9.75%.

Shree Ganesh Remedies Ltd's Key Ratios

Shree Ganesh Remedies Ltd has a market cap of ₹2.99 billion, indicating a price to book ratio of 4.4621 and a price to sales ratio of 3.8242.

In the last 12-months Shree Ganesh Remedies Ltd’s revenue was ₹0 with a gross profit of ₹265.03 million and an EBITDA of ₹0. The EBITDA ratio measures Shree Ganesh Remedies Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Shree Ganesh Remedies Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q4, Shree Ganesh Remedies Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Shree Ganesh Remedies Ltd’s PE and PEG Ratio

Forward PE

0

Trailing PE

28.5721

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Shree Ganesh Remedies Ltd’s profitability.

Shree Ganesh Remedies Ltd stock is trading at a EV to sales ratio of 4.1002 and a EV to EBITDA ratio of 14.1482. Its price to sales ratio in the trailing 12-months stood at 3.8242.

Shree Ganesh Remedies Ltd stock pays annual dividends of ₹1.345 per share, indicating a yield of 0.46% and a payout ratio of 5.38%.

Balance sheet and cash flow metrics

Total Assets

₹1.11 billion

Total Liabilities

₹128.09 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

5.38%

Shree Ganesh Remedies Ltd ended 2024 with ₹1.11 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.11 billion while shareholder equity stood at ₹691.00 million.

Shree Ganesh Remedies Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹128.09 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹71.20 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹288.46 million.

Shree Ganesh Remedies Ltd’s total current assets stands at ₹447.75 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹151.98 million compared to accounts payable of ₹0 and inventory worth ₹186.84 million.

In 2024, Shree Ganesh Remedies Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Shree Ganesh Remedies Ltd paid ₹0.05 in dividends in 2024.

Other key metrics

Current Trading Price

₹489.65

52-Week High

₹333

52-Week Low

₹213.2

Analyst Target Price

₹

Shree Ganesh Remedies Ltd stock is currently trading at ₹489.65 per share. It touched a 52-week high of ₹333 and a 52-week low of ₹333. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹426.33 and 200-day moving average was ₹316.61 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.